Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Gluteal vs Deltoid Risperidone Injection in Schizophrenia
NCT00843687Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in schizophrenia, sponsored by Johnson & Johnson. Started Sep 2005; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00843687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843687.